切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2018, Vol. 07 ›› Issue (05) : 345 -349. doi: 10.3877/cma.j.issn.2095-3232.2018.05.001

所属专题: 综述 文献

述评

肝切除术后肝衰竭早期诊断及预防
蒋贝格1, 周伟平1,()   
  1. 1. 200438 上海,海军军医大学附属东方肝胆外科医院肝外三科
  • 收稿日期:2018-07-11 出版日期:2018-10-10
  • 通信作者: 周伟平
  • 基金资助:
    传染病十三五重大专项(2017ZX10203208); 国家自然基金创新团体(81521091)

Early diagnosis and prevention of liver failure after hepatectomy

Beige Jiang1, Weiping Zhou1()   

  • Received:2018-07-11 Published:2018-10-10
  • Corresponding author: Weiping Zhou
引用本文:

蒋贝格, 周伟平. 肝切除术后肝衰竭早期诊断及预防[J/OL]. 中华肝脏外科手术学电子杂志, 2018, 07(05): 345-349.

Beige Jiang, Weiping Zhou. Early diagnosis and prevention of liver failure after hepatectomy[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2018, 07(05): 345-349.

表1 ISGLS PHLF分级标准[2]
[1]
Russell MC. Complications following hepatectomy[J]. Surg Oncol Clin N Am, 2015, 24(1):73-96.
[2]
Rahbari NN, Garden OJ, Padbury R, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS)[J]. Surgery, 2011, 149(5):713-724.
[3]
Zheng Y, Yang H, He L, et al. Reassessment of different criteria for diagnosing post-hepatectomy liver failure: a single-center study of 1683 hepatectomy[J]. Oncotarget, 2017, 8(51):89269-89277.
[4]
Chuang YH, Ou HY, Lazo MZ, et al. Predicting post-hepatectomy liver failure by combined volumetric, functional MR image and laboratory analysis[J]. Liver Int, 2018, 38(5):868-874.
[5]
van den Broek MA, Olde Damink SW, Dejong CH, et al. Liver failure after partial hepatic resection: definition, pathophysiology, risk factors and treatment[J]. Liver Int, 2008, 28(6):767-780.
[6]
Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts[J]. Hepatology, 2000, 31(4):864-871.
[7]
Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease[J]. Hepatology, 2001, 33(2):464-470.
[8]
Qadan M, Garden OJ, Corvera CU, et al. Management of postoperative hepatic failure[J]. J Am Coll Surg, 2016, 222(2):195-208.
[9]
Balzan S, Belghiti J, Farges O, et al. The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy[J]. Ann Surg, 2005, 242(6):824-828.
[10]
Reissfelder C, Rahbari NN, Koch M, et al. Postoperative course and clinical significance of biochemical blood tests following hepatic resection[J]. Br J Surg, 2011, 98(6):836-844.
[11]
Kauffmann R, Fong Y. Post-hepatectomy liver failure[J]. Hepatobiliary Surg Nutr, 2014, 3(5):238-246.
[12]
Ross SW, Seshadri R, Walters AL, et al. Mortality in hepatectomy: model for end-stage liver disease as a predictor of death using the National Surgical Quality Improvement Program database[J]. Surgery, 2016, 159(3):777-792.
[13]
Wagener G. Assessment of hepatic function, operative candidacy, and medical management after liver resection in the patient with underlying liver disease[J]. Semin Liver Dis, 2013, 33(3):204-212.
[14]
Vauthey JN, Dixon E, Abdalla EK, et al. Pretreatment assessment of hepatocellular carcinoma: expert consensus statement[J]. HPB, 2010, 12(5):289-299.
[15]
Narita M, Oussoultzoglou E, Bachellier P, et al. Post-hepatectomy liver failure in patients with colorectal liver metastases[J]. Surg Today, 2015, 45(10):1218-1226.
[16]
Schnitzbauer AA, Lang SA, Goessmann H, et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings[J]. Ann Surg, 2012, 255(3):405-414.
[17]
Imamura H, Sano K, Sugawara Y, et al. Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test[J]. J Hepatobiliary Pancreat Surg, 2005, 12(1):16-22.
[18]
Chu CM, Chen YC, Tai DI, et al. Level of hepatitis B virus DNA in inactive carriers with persistently normal levels of alanine aminotransferase[J]. Clin Gastroenterol Hepatol, 2010, 8(6):535-540.
[19]
Huang G, Lai EC, Lau WY, et al. Posthepatectomy HBV reactivation in hepatitis B-related hepatocellular carcinoma influences postoperative survival in patients with preoperative low HBV-DNA levels[J]. Ann Surg, 2013, 257(3):490-505.
[20]
Yamazaki O, Matsuyama M, Horii K, et al. Comparison of the outcomes between anatomical resection and limited resection for single hepatocellular carcinomas no larger than 5 cm in diameter: a single-center study[J]. J Hepatobiliary Pancreat Sci, 2010, 17(3): 349-358.
[21]
Nanashima A, Sumida Y, Abo T, et al. Comparison of survival between anatomic and non-anatomic liver resection in patients with hepatocellular carcinoma: significance of surgical margin in non-anatomic resection[J]. Acta Chir Belg, 2008, 108(5):532-537.
[22]
邓国荣,陈博艺,李荣,等.术前血小板淋巴细胞比率对肝细胞癌患者的临床意义分析[J/CD].中华普通外科学文献(电子版),2017, 11(1):13-17.
[23]
Alkozai EM, Nijsten MW, de Jong KP, et al. Immediate postoperative low platelet count is associated with delayed liver function recovery after partial liver resection[J]. Ann Surg, 2010, 251(2):300-306.
[24]
张军,许建伟,殷凯,等.肝癌肝部分切除术后患者血小板计数与肝功能恢复的相关性研究[J].肝胆胰外科杂志,2012, 24(5): 359-361.
[25]
Otsuka Y, Duffy JP, Saab S, et al. Postresection hepatic failure: successful treatment with liver transplantation[J]. Liver Transpl, 2007, 13(5):672-679.
[1] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[2] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[3] 冯旺, 马振中, 汤林花. CT扫描三维重建在肝内胆管细胞癌腹腔镜肝切除术中的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 104-107.
[4] 赖全友, 高远, 汪建林, 屈士斌, 魏丹, 彭伟. 三维重建技术结合腹腔镜精准肝切除术对肝癌患者术后CD4+、CD8+及免疫球蛋白水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 651-654.
[5] 唐梅, 周丽, 牛岑月, 周小童, 王倩. ICG荧光导航的腹腔镜肝切除术临床意义[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 655-658.
[6] 屈翔宇, 张懿刚, 李浩令, 邱天, 谈燚. USP24及其共表达肿瘤代谢基因在肝细胞癌中的诊断和预后预测作用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 659-662.
[7] 公宇, 廖媛, 尚梅. 肝细胞癌TACE术后复发影响因素及预测模型建立[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 818-824.
[8] 李一帆, 朱帝文, 任伟新, 鲍应军, 顾俊鹏, 张海潇, 曹耿飞, 阿斯哈尔·哈斯木, 纪卫政. 血GP73水平在原发性肝癌TACE疗效评价中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 825-830.
[9] 刘敏思, 李荣, 李媚. 基于GGT与Plt比值的模型在HBV相关肝细胞癌诊断中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 831-835.
[10] 关小玲, 周文营, 陈洪平. PTAAR在乙肝相关慢加急性肝衰竭患者短期预后中的预测价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 841-845.
[11] 焦振东, 惠鹏, 金上博. 三维可视化结合ICG显像技术在腹腔镜肝切除术治疗复发性肝癌中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 859-864.
[12] 陈晓鹏, 王佳妮, 练庆海, 杨九妹. 肝细胞癌VOPP1表达及其与预后的关系[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 876-882.
[13] 袁雨涵, 杨盛力. 体液和组织蛋白质组学分析在肝癌早期分子诊断中的研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 883-888.
[14] 吴警, 吐尔洪江·吐逊, 温浩. 肝切除术前肝功能评估新进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 889-893.
[15] 吴雪云, 胡小军, 范应方. 肝切除术中剩余肝再生能力的评估与预测[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 894-897.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?